Friday, October 28, 2011

Fast 100: Discovery, deals boost Five Prime's bottom line

Five Prime Therapeutics Inc. is an anomaly.
A drug-development company without any drugs on the market, South San Francisco-based Five Prime has increased revenue in each of the past three years, reaching $23.7 million last year while hitting a three-year compound growth rate of more than 52 percent.
What’s more, Five Prime expects a double-digit percentage point jump in revenue in 2011.

No comments:

Post a Comment